Filed: 11/12/2024ACC: 0001123292-24-000336
📋 What this filing means
ATHYRIUM CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $8.69M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$8.69M
Total AUM (reported)
12.19M
Total Shares
Allocation by class
COM NEW$5.48M63.1%
COM$3.20M36.9%
Portfolio Concentration
Top 3$8.69M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 12.19M
Sole
Full voting authority
12.19M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Biora Therapeutics Inc.
SOLEShares10.93M
TypeSH
Market value$5.48M
63.12%
Sole
10.93M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares1.26M
TypeSH
Market value$3.20M
36.88%
Sole
1.26M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Biora Therapeutics Inc.SOLE | COM NEW | 10.93M | SH | $5.48M 63.12% | 10.93M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 1.26M | SH | $3.20M 36.88% | 1.26M | 0.00 | 0.00 |